Old Web
English
Sign In
Acemap
>
authorDetail
>
Catherine Ntabadde
Catherine Ntabadde
Merck & Co.
Endocrinology
Internal medicine
Diabetes mellitus
Medicine
Placebo
2
Papers
66
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study
2019
Diabetes, Obesity and Metabolism
Juan P. Frias
Zachary Zimmer
Raymond Lam
Guillermo Amorin
Catherine Ntabadde
Carol Iredale
Edward A. O’Neill
Samuel S. Engel
Keith D. Kaufman
Hideo Makimura
Michael F. Crutchlow
Show All
Source
Cite
Save
Citations (3)
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
2017
Cardiovascular Diabetology
Ira Gantz
Menghui Chen
Shailaja Suryawanshi
Catherine Ntabadde
Sukrut Shah
Edward A. O’Neill
Samuel S. Engel
Keith D. Kaufman
Eseng Lai
Show All
Source
Cite
Save
Citations (63)
1